News


Jun 27, 2008	Olympian, Legendary Swimmer Gary Hall Jr. Teams With Lilly to Serve as Ambassador for Inspired By Diabetes Campaign
Jun 27, 2008	European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
Jun 25, 2008	Lilly Sets Date and Conference Call for Second Quarter 2008 Financial Results Announcement
Jun 23, 2008	FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
Jun 23, 2008	Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
Jun 16, 2008	FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Jun 13, 2008	Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Jun 12, 2008	Lilly and TransPharma Medical Announce Licensing and Development Agreement
Jun 10, 2008	Lilly's Connelly Appointed to the President's Commission on White House Fellowships
Jun 9, 2008	After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008
Jun 9, 2008	Lilly to Provide Aid to Indiana Tornado and Flood Victims
Jun 9, 2008	When Words Fail ... Cancer Art Competition Gives Rise to Expression and Hope
Jun 7, 2008	Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
Jun 7, 2008	Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
Jun 5, 2008	Inspired by Diabetes U.S. National Contest Winners Share Stories of Perseverance and Success in Managing Diabetes
May 29, 2008	Art Exhibit Honors National Cancer Survivors Day
May 29, 2008	Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
May 28, 2008	Study Showed ALIMTA(R) (pemetrexed for injection) Improved Survival in Certain Types of Non-Small Cell Lung Cancer
May 21, 2008	Lilly Announces Changes in Key Leadership Roles
May 20, 2008	Lilly to Provide More Than $1 Million in Disaster Aid
May 19, 2008	American Psychiatric Foundation, Lilly Foundation and Give an Hour Join Forces to Provide Mental Health Care to Iraq and Afghanistan Veterans
May 15, 2008	ASCO Study Confirms Importance of Histology in Treatment of Non-Small Cell Lung Cancer With ALIMTA (pemetrexed for injection)
May 15, 2008	Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service
May 15, 2008	Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service
May 14, 2008	Lilly Employees from Nearly 50 Nations Participate in Company's First-Ever Global Day of Service
May 13, 2008	Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
May 13, 2008	More Than 8,400 Lilly Employees to Participate in Massive One-Day City Makeover May 15
May 12, 2008	Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
May 8, 2008	FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
May 2, 2008	2008 Welcome Back Awards Winners Honored for Extraordinary Achievements in the Field of Depression
May 1, 2008	Lilly Oncology to Unveil More Than 50 Studies at ASCO 2008
Apr 30, 2008	Lilly CEO Praises Massachusetts' Leadership in Biotech, Urges Policy Prescriptions to Help Ensure State's Investment Generates Dividends and Jobs
Apr 30, 2008	Lilly CEO Urges Policy Prescriptions to Help Ensure Public and Private Biotech Investments Generate Dividends and U.S. Job Growth
Apr 21, 2008	Lilly Declares Second-Quarter Dividend
Apr 21, 2008	Lilly Reports Solid First-Quarter Results
Apr 16, 2008	Mental Health Prescription Program Named Winner in URAC's Best Practices in Consumer Empowerment and Protection Awards
Apr 16, 2008	Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
Apr 15, 2008	Neo-Soul Singer Angie Stone Belts a New Tune: Be Fearless in the FACE of Diabetes
Apr 4, 2008	FORSTEO(R) Receives Approval from the European Commission for the Treatment of Glucocorticoid-Induced Osteoporosis
Apr 2, 2008	Lilly Adjusts Time of Conference Call for First Quarter 2008 Financial Results Announcement
Mar 31, 2008	Lilly Launches Its First Phase III Trial for Treatment of Alzheimer's Disease
Mar 29, 2008	Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
Mar 26, 2008	Lilly Sets Date and Conference Call for First Quarter 2008 Financial Results Announcement
Mar 14, 2008	Statement from Eli Lilly and Company: Response to Today's New York Times Article, 'Lilly E-Mail Discussed Off-Label Drug Use'
Mar 13, 2008	Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Mar 12, 2008	Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Mar 12, 2008	Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion
Mar 11, 2008	Lilly Offers Helping Hand in Fight Against Chronic Disease
Mar 7, 2008	Lilly Announces Termination of AIR Insulin Program
Mar 5, 2008	Mental Health Parity Laudable, But House Legislation Would Put Medicaid Patients at Risk, Lilly Says
Feb 28, 2008	FDA Issues Not-Approvable Letter for Lilly's Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Feb 26, 2008	Lilly and Partners In Health, Brigham and Women's Hospital Team Up to Fight MDR-TB in Former Soviet Republics
Feb 21, 2008	FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
Feb 19, 2008	Michael L. Eskew Elected to Lilly Board of Directors
Feb 6, 2008	FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
Jan 29, 2008	Lilly Caps Successful Year with Strong Fourth-Quarter Results
Jan 18, 2008	In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
Jan 8, 2008	FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
Jan 4, 2008	Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement
Jan 4, 2008	Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
Dec 18, 2007	Sidney Taurel to Retire as Lilly CEO; John Lechleiter Named as Successor
Dec 17, 2007	Lilly and BioMS Medical Announce Global Licensing and Development Agreement
Dec 17, 2007	Lilly Announces Dividend Increase
Dec 14, 2007	Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
Dec 6, 2007	Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
Dec 5, 2007	Lilly Announces New President of Animal Health Division
Dec 5, 2007	Lilly Announces Pat James to Assume New Role
Nov 30, 2007	FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
Nov 29, 2007	International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
Nov 15, 2007	When Words Fail ... Cancer Patients Unite to Express Their Journeys on Canvas
Nov 15, 2007	Eli Lilly and Company to Receive Honor from National Urban League
Nov 14, 2007	FORTEO(R) Increased Spine Bone Mineral Density in Patients with Glucocorticoid-Induced Osteoporosis
Nov 13, 2007	Deadline Extended to Submit Nominations for 10th Anniversary of Depression Awards Program
Nov 9, 2007	The Lilly MDR-TB Partnership Provides Unique Model for Fight Against Multidrug-Resistant Tuberculosis in South Africa
Nov 6, 2007	Lilly Contributes $10.8 Million to United Way Annual Campaign
Nov 6, 2007	NBC 'Today' Co-Host Al Roker to Serve as a National Ambassador for Inspired by Diabetes Campaign to Help Children With Diabetes
Nov 6, 2007	Lilly Receives NCQA Design Certification for Depression Care Management Program
Oct 31, 2007	2007 Luminous Award Winners Highlight Ovarian Cancer Treatment and the Importance of Early Detection
Oct 30, 2007	Lilly Sets Date and Time for American Heart Association Conference Call
Oct 30, 2007	Lilly and Glenmark Pharmaceuticals Announce License Agreement
Oct 29, 2007	Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Oct 26, 2007	Eli Lilly and Company Aids California Recovery Effort
Oct 24, 2007	Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies
Oct 18, 2007	Lilly Delivers Strong Third-Quarter Results
Oct 18, 2007	Lilly and MacroGenics Announce Licensing and Collaboration Agreement
Oct 5, 2007	Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
Oct 2, 2007	Lilly's CEO Calls for Reform of Nation's Drug Safety System
Sep 25, 2007	Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
Sep 25, 2007	Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
Sep 20, 2007	Lilly Sets Date and Conference Call for Third Quarter 2007 Financial Results Announcement
Sep 20, 2007	Baseline Data From European Observational Study Highlights Characteristics of Patients with Type 2 Diabetes Initiating Insulin
Sep 18, 2007	Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
Sep 18, 2007	The Welcome Back Awards Now Accepting Nominations to Honor Courageous Individuals Dedicated to the Depression Community
Sep 18, 2007	European Study Outlines Struggle to Control Diabetes, Significant Economic Implications to Healthcare Systems
Sep 7, 2007	Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
Sep 4, 2007	Data Affirm Benefit of ALIMTA (R) (pemetrexed for injection) for Patients With Malignant Pleural Mesothelioma
Sep 3, 2007	Data Affirm Benefit of ALIMTA(R) (pemetrexed for injection) for Patients with Non-Small Cell Lung Cancer
Sep 2, 2007	Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
Aug 21, 2007	New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Jul 24, 2007	FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk for Invasive Breast Cancer in Two Populations of Postmenopausal Women
Jul 24, 2007	Lilly Reports Strong Second-Quarter Results; Raises Full-Year Sales and EPS Guidance
Jul 11, 2007	European Commission Approves FORSTEO(R) (teriparatide [rDNA origin] injection) for the Treatment of Osteoporosis in Men
Jul 10, 2007	Breast Cancer Survivor Jaclyn Smith Urges Women to Know Their Breast Cancer Risk Factors
Jul 4, 2007	Researchers Identify Genetic Mutation That May Alter Patients' Response to Cancer Therapeutics
Jun 29, 2007	Lilly Sets Date and Conference Call for Second Quarter 2007 Financial Results Announcement
Jun 21, 2007	Lilly Declares Third-Quarter Dividend
Jun 21, 2007	Lilly, International Diabetes Federation and American Diabetes Association Announce U.S. Launch of 'Inspired by Diabetes' Creative Expression Competition
Jun 20, 2007	Academy of Family Physicians Foundation Will Launch New Model of Peer Support to Drive Behavior Changes in People with Diabetes
Jun 20, 2007	Chicago Community Leaders Come Together to Confront the Diabetes Epidemic
Jun 13, 2007	Lilly Unveils Ambitious Partnership for Tuberculosis Drug Discovery
Jun 13, 2007	Lilly Tuberculosis Partnership Honored By Global Business Coalition
Jun 13, 2007	Dale M. Edgar, Ph.D., to Join Lilly; Will Head Lilly Research Lab's Discovery Sleep Research Efforts
Jun 7, 2007	Eli Lilly and Company Comments on Recent Court Rulings Regarding Zyprexa(R) Patents
Jun 6, 2007	Lilly Partners With the Make-A-Wish Foundation(R) of Greater Ohio, Kentucky & Indiana, Indiana Region to Grant Four Local Wishes
Jun 5, 2007	National Campaign Showcases the Importance of Joining Forces With 'Man's Best Friend' in Overcoming Depression
Jun 2, 2007	Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
Jun 2, 2007	Study Supports Activity of GEMZAR(R) (Gemcitabine HC1 for Injection) in the Treatment of Early-Stage Breast Cancer
Jun 2, 2007	Targeted, Oral Agent Enzastaurin Shows Favorable Results in Late-Stage Lung Cancer
Jun 1, 2007	Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment
Jun 1, 2007	Lilly Announces a Call for Articles Into 2007 Luminous Award
May 25, 2007	Lilly Announces Senior Leadership Change in Manufacturing
May 23, 2007	In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, In Reducing Painful Symptoms in SSRI Non- or Partial-responders with Depression
May 23, 2007	Workplace Burden of Depression Magnified by Co-morbid Fatigue and Anxiety, New Study Shows
May 23, 2007	Study Suggests Strattera(R) Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
May 23, 2007	Making Science Personal: Lilly Oncology to Unveil 76 Studies at ASCO 2007
May 21, 2007	Data Suggest Cymbalta(R) Improved Functioning in Patients with Generalized Anxiety Disorder
May 9, 2007	Lilly Announces New Employee Policy
May 4, 2007	Lilly Announces Senior Leadership Changes
May 3, 2007	Data Suggest Cymbalta(R) Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
May 1, 2007	Lilly to Publish Information on Grants and Contributions
Apr 20, 2007	In The Top 10 Most Romantic Cities, Spring is Here and Boomer Couples are Ready!
Apr 19, 2007	New Survey Shows Most Physicians Believe Diabetes Patients Are Not Receiving Appropriate Care For Diabetic Nerve Pain
Apr 16, 2007	Lilly Declares Second-Quarter Dividend
Apr 16, 2007	Lilly and the AACR Work Together To Recognize Breakthrough Research in the Fight Against Cancer
Apr 16, 2007	Lilly Reports Strong First-Quarter Results; Raises Full-Year Sales and EPS Guidance
Apr 15, 2007	Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting
Apr 3, 2007	Lilly Announces Completion of Hypnion Acquisition
Apr 3, 2007	New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia
Mar 29, 2007	Lilly Sets Date and Conference Call for First Quarter 2007 Financial Results Announcement
Mar 26, 2007	Enzastaurin Granted Orphan Drug Status for Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Mar 22, 2007	Lilly Announces Additional $50 Million Investment in Global Tuberculosis Partnership
Mar 14, 2007	Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the Impact of Aging
Mar 9, 2007	Lilly Oncology on Canvas(SM) Kicks Off 2007 World Tour With Month-Long Exhibition in Indianapolis
Mar 5, 2007	Lilly Announces Acquisition of Hypnion
Feb 26, 2007	Lilly Plans New Clinical Trial of Xigris(R)
Feb 14, 2007	Eli Lilly and Company Statement: Judge Grants Lilly's Request for a Permanent Injunction Involving Misleading Selection of Illegally Leaked Lilly Documents
Feb 12, 2007	Scholarship Recognizes Adults With Attention-Deficit/Hyperactivity Disorder Striving for Academic Excellence
Feb 12, 2007	PQIP Improves Medicaid Quality Of Care For Individuals With Mental Illness
Jan 31, 2007	Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and Reported EPS of $2.45
Jan 29, 2007	Lilly Announces Completion of ICOS Corporation Acquisition
Jan 16, 2007	Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to Clopidogrel in Patients With Acute Coronary Syndrome
Jan 11, 2007	Lilly Announces Strategic Changes to its Global Manufacturing Operations
Jan 5, 2007	Lilly and OSI Pharmaceuticals Announce Licensing Agreement
Jan 4, 2007	Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
Jan 4, 2007	Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2006 Financial Results Announcement
Jan 4, 2007	Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
Dec 21, 2006	Eli Lilly and Company Statement Regarding Today's New York Times Article - December 21, 2006
Dec 21, 2006	Data Monitoring Committee Recommends Closing Enrollment in Recurrent Glioblastoma Study
Dec 18, 2006	Lilly Announces Dividend Increase
Dec 18, 2006	Statement from Eli Lilly and Company: Response to The New York Times Article from December 18, 2006
Dec 7, 2006	Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of Invasive Breast Cancer Risk in Postmenopausal Women
Dec 7, 2006	Lilly Delivers Promising Update to Wall Street on Strategic Priorities, Pipeline Progress and Earnings Guidance
Dec 6, 2006	'This is Not a Dress Rehearsal' Captures Cancer Patient's Spirit and Wins Lilly Oncology on Canvas(SM) Art Competition
Nov 21, 2006	BYETTA(R) (exenatide) Approved for Treatment of Type 2 Diabetes by European Commission
Nov 20, 2006	Deadline Extended to Submit Nominations for Depression Awards Program
Nov 13, 2006	Eli Lilly and Company Foundation To Fund World-Class Diabetes Treatment and Care Program at Riley Hospital for Children
Nov 13, 2006	Ruboxistaurin Reduced Vision Loss in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study
Nov 3, 2006	'Hair Again' Gives Cancer Journey Meaning
Oct 27, 2006	Study Suggests Strattera(R) was Effective in Treating ADHD in Children and Adolescents with ADHD and Reading Disorders
Oct 23, 2006	New Study Shows Prasugrel Achieves Faster Onset and Higher Levels of Platelet Inhibition than Clopidogrel at Approved or Higher Doses
Oct 23, 2006	Lilly Expands Biotech Capabilities to Match Expanding Biotech Pipeline
Oct 20, 2006	Lilly Launches Phase III 'GALES' Trial of ALIMTA(R) (Pemetrexed for Injection) in Small Cell Lung Cancer
Oct 19, 2006	Lilly ICOS LLC Reports Record Sales for Third Quarter of 2006
Oct 19, 2006	Lilly Reports 7% Sales Growth, 10% Earnings Growth and $.80 EPS for Third Quarter
Oct 18, 2006	In Response to a Letter to the Editor That Appears in the Oct. 19, 2006, Issue of the New England Journal of Medicine, Eli Lilly and Company Provides the Following Statement:
Oct 17, 2006	Lilly Announces Acquisition of ICOS Corporation
Oct 16, 2006	Lilly Declares Fourth-Quarter Dividend
Oct 10, 2006	Eli Lilly and Company Announces 2006 Lilly Reintegration Awards Recipients
Sep 29, 2006	Lilly Announces FDA Requirement of Additional Clinical Trial Before Ruboxistaurin Could Be Approved for Treatment of Diabetic Retinopathy
Sep 28, 2006	2006 Lilly Oncology on Canvas(SM) International Art Competition Receives More Than 2,000 Entries
Sep 27, 2006	Lilly Seeks Entries for the Second Annual Adult ADHD Focus on Your Possibilities Scholarships
Sep 26, 2006	Government Approves Lilly's Medicare Part D Patient Assistance Program
Sep 25, 2006	Lilly Sets Date and Conference Call for Third Quarter 2006 Financial Results Announcement
Sep 21, 2006	Exenatide Receives Positive Opinion From the European Committee for Medicinal Products for Human Use for the Treatment of Type 2 Diabetes
Sep 16, 2006	New Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Insulin Glargine
Sep 14, 2006	Lilly Celebrates 10 Years of Better Mealtime Blood Sugar Control with Humalog(TM)
Sep 14, 2006	Lilly Receives NCQA Program Design Certification for Several Disease Management Programs
Sep 14, 2006	Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Biphasic Insulin Aspart
Sep 14, 2006	Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes
Sep 12, 2006	Awards Program Seeks to Honor Five Innovators in the Depression Community
Sep 12, 2006	Lilly Announces LillyforLife(TM) Achievement Award Winners
Sep 11, 2006	Oncology Researchers Recognized as Heroes of Chemistry
Sep 8, 2006	Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the Impact of Aging
Aug 31, 2006	Lilly's Taurel Calls for Japan-U.S. Economic Integration Agreement
Aug 18, 2006	Eli Lilly and Company Announces Approvable Letter Issued by FDA for Arxxant(TM) (ruboxistaurin mesylate)
Jul 28, 2006	Mental Health Prescription Program Announces Extension Through 2006
Jul 25, 2006	Older Does Not Always Mean Wiser: Survey Finds Postmenopausal Women Less Concerned About Breast Cancer Than Younger Women
Jul 21, 2006	Lilly ICOS LLC Reports Record Sales and Net Income for Second Quarter of 2006
Jul 21, 2006	Lilly Reports Second-Quarter EPS of $.76
Jul 21, 2006	Lilly and Alcon Sign Marketing Collaboration for Potentially the First Oral Medication for Diabetic Retinopathy
Jul 17, 2006	FDA Approves Lilly's Gemzar(R) For Ovarian Cancer Treatment
Jun 26, 2006	Lilly Declares Third-Quarter Dividend
Jun 22, 2006	Lilly Sets Date and Conference Call for Second Quarter 2006 Financial Results Announcement
Jun 22, 2006	Sexual Revolutionaries Mature: Baby Boomers Seek Relationship Satisfaction
Jun 11, 2006	Investigational Treatment Ruboxistaurin Demonstrated Promise in Reducing the Occurrence of Vision Loss Caused by Diabetic Retinopathy
Jun 10, 2006	BYETTA(R) Shown to Reduce Blood Glucose Levels When Added to Patients Using a TZD
Jun 10, 2006	Data on AIR(R) Inhaled Insulin System Presented at American Diabetes Association Meeting
Jun 10, 2006	BYETTA(R) Extension Study Shows Sustained Improvements in Blood Glucose Control and Progressive Weight Loss After Two Years
Jun 10, 2006	New Study Illustrates Economic Benefit of Weight Loss in People with Type 2 Diabetes
Jun 10, 2006	Study Demonstrated Once-Weekly Exenatide LAR Improved Glucose Control in Patients with Type 2 Diabetes
Jun 4, 2006	Lilly Announces Phase II Results for ALIMTA(R) in First-Line Metastatic Breast Cancer Trial
Jun 4, 2006	New Data Show Enzastaurin's Activity Across Multiple Cancer Cell Lines
Jun 4, 2006	Updated Analysis in Second-Line Treatment of Lung Cancer Trial Confirms Similar Survival for Alimta(R) and Docetaxel
Jun 3, 2006	Lilly Breast Cancer Studies Explore Potential Role of Pharmacogenomics in Customizing Chemotherapy
Jun 2, 2006	Lilly Launches New Award To Promote Enlightened Oncology Reporting
May 31, 2006	Lilly Launches Phase III Trial of Once-Daily, Targeted Oral Cancer Agent
May 24, 2006	Study Suggests Atomoxetine Significantly Improved Functioning in Children with Both ADHD and Anxiety Disorders
May 23, 2006	New Study Suggests Symbyax(R) Significantly Improves Symptoms of Treatment-Resistant Depression
May 23, 2006	Lilly Oncology Prepares for Strong Showing at ASCO 2006; Targets Breast Cancer and Other Tumors with 79 Studies
May 22, 2006	New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
May 22, 2006	First Head-to-Head Study Suggests Significantly Greater Symptom Improvement for Symbyax(R) Compared to Lamotrigine in Bipolar Depression
May 22, 2006	Lilly Offers Tips for Disaster Preparation for Diabetes
May 19, 2006	2006 Welcome Back Awards Winners Honored for Helping Reshape the Mental Health System
May 10, 2006	Lilly to Extend Patient Assistance Programs for Medicare Patients
May 9, 2006	Lilly Submits Cymbalta(R) Supplemental New Drug Application for Generalized Anxiety Disorder
May 4, 2006	Jury Issues Verdict in Ariad v. Lilly Patent Infringement Suit
Apr 24, 2006	Lilly Declares Second-Quarter Dividend
Apr 20, 2006	Lilly ICOS LLC Reports Results for First Quarter of 2006
Apr 20, 2006	Lilly Reports Q1 EPS of $.77, or 13% Growth
Apr 18, 2006	National Survey Emphasizes Women Need More Comprehensive Approach to Managing Depression
Apr 17, 2006	Lilly Statement on STAR
Apr 12, 2006	Lilly Announces Preliminary Coronary and Breast Cancer Results from Raloxifene Use for The Heart (RUTH) Study
Apr 6, 2006	New Data Show Cialis(R) (tadalafil) is Effective in Treating Erectile Dysfunction Caused by Traumatic Spinal Cord Injury
Apr 6, 2006	Study Examines Continued Economic Burden of Acute Coronary Syndrome Despite Standard Medical Interventions
Apr 1, 2006	CATIE Phase 2 Data Confirm Patients Stay on Treatment Longer Because of Symptom Improvement More So Than Tolerability
Mar 30, 2006	Lilly Announces Senior Leadership Changes
Mar 29, 2006	Call for Journalists to Enter the Embrace Award for Accurate, Responsible and Sensitive Reporting of Urinary Incontinence
Mar 24, 2006	Study Suggests Cymbalta(R) Significantly Reduces Core Anxiety Symptoms of Generalized Anxiety Disorder
Mar 22, 2006	Lilly Sets Date and Conference Call for First Quarter 2006 Financial Results Announcement
Mar 20, 2006	Lilly and Biosite to Collaborate on Clinical Trial Using Tailored Xigris Therapy
Mar 14, 2006	Study Shows More Potent and More Reliable Platelet Inhibition with Prasugrel Compared to Clopidogrel Even in Patients With More Reactive Platelets
Mar 9, 2006	Lilly Launches Phase III Trial of Targeted Cancer Agent
Feb 23, 2006	Lilly's Charles E. Golden Announces Retirement
Feb 21, 2006	Lilly Global Philanthropy Exceeds $500 Million in 2005
Feb 15, 2006	Eli Lilly and Company and Boehringer Ingelheim Announce Changes to Their Contractual Agreements for Yentreve(R)/AriClaim(R)
Feb 14, 2006	Study Finds Cymbalta(R) Was As Safe And Well-Tolerated As Routine Drug Treatments For Diabetic Nerve Pain
Feb 7, 2006	Lilly Launches Humalog(R) Mix50/50(TM) Insulin in United States
Feb 3, 2006	Combating Cancer with Color and Canvas: Lilly Oncology on Canvas(TM) International Art Competition Call for Entries
Jan 26, 2006	Lilly Reports Q4 EPS of $.64, or $.80 Excluding Charges; 2005 EPS of $1.81, or $2.87 Excluding Charges
Jan 24, 2006	Women's First Pregnancy and Delivery Creates Risk for Stress Urinary Incontinence (SUI)
Jan 20, 2006	Lilly ICOS LLC Reports First Full-Year Profit in its History
Jan 18, 2006	LillyforLife(TM) Ambassador Kris Freeman Named to 2006 U.S. Olympic Ski Team
Jan 3, 2006	Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2005 Financial Results Announcement
Dec 22, 2005	Lilly to Take Asset Impairment Charges in Fourth Quarter of 2005
Dec 21, 2005	Lilly Resolves Investigation of Its Evista Marketing and Promotional Practices
Dec 20, 2005	New Study Showed No Difference in Total Treatment Costs When Comparing Those Starting Treatment with Older Conventional Antipsychotics and Those Starting Treatment with Zyprexa(R), an Atypical Antipsychotic, in the Treatment of Schizophrenia
Dec 19, 2005	Lilly Announces Dividend Increase
Dec 13, 2005	New Study Suggests Cymbalta(R) Reduced Depression Symptoms At Least As Fast As a Leading Competitor
Dec 10, 2005	Investigational Targeted Therapy May Offer Progress for Non-Hodgkin's Lymphoma Patients
Dec 9, 2005	Lilly Plans to Submit Cymbalta(R) (duloxetine hydrochloride) New Drug Application for Generalized Anxiety Disorder
Dec 9, 2005	Lilly Tells Wall Street It's Uniquely Positioned To Deliver Sustained Growth
Nov 17, 2005	Deadline Extended to Submit Nominations for Depression Awareness Award
Nov 10, 2005	National Survey Finds Weight Gain, Patient-Provider Communication and New Medical Options Critical Factors for Controlling Type 2 Diabetes
Nov 8, 2005	From the Gridiron to the State House to Cable Television: Champions in Fight Against Mental Illness to be Honored by Lilly
Nov 7, 2005	November 14 Deadline Approaching to Submit Nominations for Depression Awareness Award
Nov 2, 2005	European School of Oncology Presents 2005 ACE Reporter Awards
Oct 31, 2005	2006 Lilly Oncology on Canvas Kicks Off with a Call for Entries
Oct 20, 2005	Lilly ICOS LLC Reports First Quarterly Profit in its History
Oct 20, 2005	Lilly Reports $.73 EPS and 10 Percent Sales Growth in the Third Quarter
Oct 17, 2005	Lilly Declares Fourth-Quarter Dividend
Oct 17, 2005	J. Erik Fyrwald Elected to Lilly Board of Directors
Oct 17, 2005	Early-Phase Data Show Prasugrel Demonstrates More Consistent Platelet Inhibition Compared to Clopidogrel
Oct 13, 2005	Lilly Announces Scholarship Recipients for Those Battling Severe Mental Illness
Oct 13, 2005	Lilly Receives NCQA Certification for Its Two Latest Disease Management Programs
Oct 5, 2005	From Relationships to Working Lives: New Global Survey Reveals the True Impact and Emotional Burden of SUI Symptoms on Women
Sep 29, 2005	Lilly Announces Important Strattera(R) Label Update
Sep 28, 2005	2006 Lilly Oncology on Canvas Kicks Off with a Call for Entries
Sep 22, 2005	Lilly Sets Date and Conference Call for Third-Quarter 2005 Earnings Announcement
Sep 22, 2005	Lilly Hits One-Year Milestone of Commitment to Disclosure of Clinical Trial Results
Sep 21, 2005	World Tour of 'Lilly Oncology on Canvas' Art Exhibit Stops at D.C.'s Historic Union Station
Sep 20, 2005	Mountain Climber Reaches First Peak As Part Of Expedition To Help People Battling Depression
Sep 20, 2005	Men Make the Grade! B+ for Overall Health Knowledge But Are They Missing the Mark for Sex Education?
Sep 20, 2005	Lilly Announces Promotion of John C. Lechleiter to President and Chief Operating Officer
Sep 19, 2005	According to CATIE, Zyprexa(R) More Effective on Discontinuation Rate than Other Antipsychotics Studied
Sep 12, 2005	Long-Term Data on Exenatide Show Sustained Improvements in Glucose Control and Progressive Weight Reduction in People With Type 2 Diabetes
Sep 12, 2005	Pilot Study of Ruboxistaurin Showed Favorable Effects on Kidney Damage and Function in People with Type 2 Diabetes and Nephropathy
Sep 12, 2005	Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin
Sep 12, 2005	Study Shows Exenatide Improves Blood Sugar Levels as Effectively as Insulin Glargine
Sep 6, 2005	Burden of ADHD Greater than Asthma, According to New Study
Aug 31, 2005	Lilly Provides Financial Support, Product Donations in Wake of Hurricane Katrina
Aug 31, 2005	Focus on Your Possibilities ADHD Scholarship Winners Announced
Aug 25, 2005	Journalists Recognised for Excellence in Reporting on One of the Last Medical Taboos
Aug 11, 2005	First of its Kind Urinary Incontinence Study Reveals Many Women With Stress Urinary Incontinence Symptoms Receive Off-Label Medications or None at All
Aug 8, 2005	New Study Provides In-Depth Look at How Osteoporosis Treatments Function Within Bone
Aug 2, 2005	Lilly Announces Support of Drug Industry Principles on Consumer Advertising of Prescription Medicines
Aug 2, 2005	Lilly Will Submit Ruboxistaurin Mesylate (Arxxant(TM)) to FDA for Treatment of Diabetic Retinopathy in 2005
Jul 21, 2005	Lilly ICOS' Cialis(R) (tadalafil) Reaches $1 Billion Global Sales Milestone
Jul 21, 2005	Lilly ICOS LLC Reports Results for Second Quarter of 2005 - Quarterly net loss narrows to $1.7 million - - Worldwide sales of Cialis(R), since launch, exceed $1 billion -
Jul 21, 2005	Lilly Reports Results for Second Quarter; Sales Increase 3 Percent
Jul 6, 2005	Lilly Licenses Oral DPP-IV Inhibitor from Taisho Pharmaceutical
Jul 5, 2005	Thoracic Cancer Patients Find New Reasons for Hope with Alimta(R)
Jul 5, 2005	Treating Lung Cancer Patients Earlier May Improve Outcomes
Jun 29, 2005	Lilly ICOS Tees Up Plans to Bring Second Year Title Sponsorship of Cialis(R) Western Open to New Level
Jun 24, 2005	Lilly Declares Third-Quarter Dividend
Jun 14, 2005	Phase 2 Study Shows Lilly/Alkermes Inhaled Insulin System Achieved Blood Sugar Levels Similar to Injected Insulin
Jun 12, 2005	Pilot Study of Ruboxistaurin Showed Favorable Effects on Kidney Damage and Function in People with Type 2 Diabetes and Nephropathy
Jun 11, 2005	Aggressive Diabetes Education Program Makes Positive Impact on Health of Medicaid Patients
Jun 11, 2005	New Data Show Cymbalta Improved Physical, Social and Emotional Functioning and Overall Health of Patients With Painful Diabetic Neuropathy
Jun 10, 2005	Long-Term Data on BYETTA(TM) Show Sustained Improvements in Glucose Control and Progressive Weight Reduction in People with Type 2 Diabetes
Jun 10, 2005	Study Shows BYETTA(TM) Improves Blood Sugar Levels as Effectively as Insulin Glargine
Jun 9, 2005	Lilly and Plaintiffs' Attorneys Enter Into an Agreement in Principle to Settle Majority of Zyprexa(R) Product Liability Litigation
Jun 9, 2005	Lilly Sets Date and Conference Call for Second-Quarter 2005 Earnings Announcement
Jun 9, 2005	Newly Approved First-in-Class Treatment for Type 2 Diabetes Is Now Available
Jun 8, 2005	New Scholarship Program to Help Adults Living With ADHD Focus on Their Possibilities
Jun 2, 2005	Lilly Announces Winners in Global Awards for Outstanding Achievements in Diabetes Care
May 31, 2005	Lilly Announces Senior Leadership Changes
May 31, 2005	Mountain Climber Leads Expedition of Hope for People Battling Depression
May 26, 2005	Regardless of Insurance Coverage, New Research Shows Vast Majority of People with Depression Are Not Effectively Treated
May 24, 2005	New Analysis Shows Cymbalta Reduced Anxiety Symptoms in Elderly Patients with Depression
May 24, 2005	New Analysis Highlights Gender Differences in ADHD Patients Treated with Atomoxetine
May 24, 2005	New Data Suggest Once-Daily Atomoxetine May Provide Symptom Relief for Up to 24 Hours
May 24, 2005	First Head-to-Head Study Shows Patients with Bipolar Depression Had Greater Symptom Improvement on Olanzapine and Fluoxetine HCl Capsules than Lamotrigine
May 24, 2005	National Coalition for Homeless Veterans Uniting Government and Public and Private Efforts to End Homelessness Among Veterans
May 23, 2005	New Study Showed Efficacy was Most Important Factor in Decision to Stay on Antipsychotic Treatment for Schizophrenia
May 23, 2005	Clinical Data Shows Lilly ICOS' Cialis(R) (tadalafil) Improves Erectile Function in ED Patients with Significant, Multiple Comorbid Conditions
May 18, 2005	Non-Stimulant Strattera More Widely Available for Attention-Deficit/Hyperactivity Disorder Patients in Europe
May 18, 2005	Non-stimulant Strattera More Widely Available for Attention- Deficit/Hyperactivity Disorder in Children and Adolescents in Europe
May 17, 2005	New Data Show Gemzar(R)-Based Combination Therapies May Provide Significant Clinical Value in Early-Stage Non-Small Cell Lung Cancer
May 17, 2005	Lilly Targeted Agent Shows Promise in Treating Primary Brain Cancer
May 17, 2005	New York Psychiatrist Wins Prestigious National Mental Health Award
May 16, 2005	NAMI-San Diego President Wins National Lifetime Achievement Award
May 16, 2005	Boston-Area Author Wins Prestigious National Mental Health Award
May 16, 2005	Connecticut Latina Wins Prestigious National Mental Health Award
May 16, 2005	Oregon Mental Health Program Founder Wins National Award
May 16, 2005	Northern Arizona Woman Wins National Mental Health Award
May 16, 2005	Welcome Back Awards Honors Unsung Heroes in the Depression Community
May 16, 2005	Lilly Does Not Endorse Below-Market Offer by TRC for 0.2 Percent of Lilly's Stock
May 16, 2005	New Study Results Demonstrate Clinical Effectiveness of Gemzar(R)-Based Combination Therapy for Advanced Breast Cancer
May 16, 2005	World Tour Of 'Oncology on Canvas' Art Exhibit To Make U.S. Debut At Harrison Center For The Arts In Indianapolis
May 3, 2005	Eli Lilly and Company Opens Nominations for 9th Annual Reintegration Awards
May 2, 2005	Pain Worsens Physical and Financial Burdens for Adults with Depression Nearing Retirement, Six-Year Study Shows
Apr 29, 2005	Lilly and Amylin Announce FDA Approval of Exenatide
Apr 29, 2005	Amylin and Lilly Announce FDA Approval of BYETTA(TM) (Exenatide) Injection
Apr 18, 2005	Lilly Declares Second-Quarter Dividend
Apr 18, 2005	Lilly ICOS LLC Reports Results for First Quarter of 2005
Apr 18, 2005	Lilly Reports $.68 Earnings Per Share in the First Quarter
Apr 18, 2005	Cialis(R) (tadalafil) Overtakes Viagra to Become Number One Selling Erectile Dysfunction Treatment in France
Apr 18, 2005	Lilly ICOS' Cialis(R) (tadalafil) Leads ED Market in France
Apr 14, 2005	U.S. District Court Rules in Favor of Lilly; Upholds Company's 2011 Patent on Zyprexa
Apr 13, 2005	U.S. District Court To Issue Ruling in the Zyprexa Patent Case on April 14 at 5:50 p.m. EDT
Apr 13, 2005	Eli Lilly and Company Pledges $12.5 Million to Accelerate Cancer Clinical Research
Apr 11, 2005	Unique New Study Suggests Significant Benefits of Yentreve(R) in Combination with Pelvic Floor Muscle Training for Women with Stress Urinary Incontinence
Apr 7, 2005	Spine Imaging Improves the Identification of Future Fracture Risk in Postmenopausal Women With Osteoporosis
Apr 6, 2005	Studies Show Schizophrenia Patients Taking Atypicals Stayed on Treatment Longer Than Patients Taking Older, Typical Antipsychotics
Mar 15, 2005	Lilly Sets Date and Conference Call for First-Quarter 2005 Earnings Announcement
Mar 15, 2005	Emmy Winning Actress Leads Charge to Pair People Battling Depression With Partners
Mar 9, 2005	Results of Early Data Show More Consistent Platelet Inhibition with Prasugrel Compared to Clopidogrel Across Three Distinct Trials
Mar 7, 2005	New Study Data Show Improved Cognitive Function in Elderly Patients Treated with Cymbalta for Depression
Mar 2, 2005	New BASS Sponsor Cialis(R) (tadalafil) Showcases Interactive Presence in Augusta
Feb 28, 2005	PGA TOUR Partner Cialis(R) (tadalafil) Debuts 2005 Consumer Golf Plans at The Ford Championship at Doral
Feb 10, 2005	Statement to the Media: Lilly ICOS Pleased with European Patent Office's Decision to Affirm Revocation of Pfizer's Patent on Treatment of Erectile Dysfunction
Feb 10, 2005	The Larry King Cardiac Foundation Receives $100,000 Grant from Lilly to Support 'Save a Heart a Day'
Feb 7, 2005	Lilly Announces Individual Bar Coding on All Insulin Vials
Feb 1, 2005	Lilly's Taurel Says American Health System is Unhealthy to the Core
Jan 28, 2005	Lilly Reconfirms Its Financial Guidance
Jan 28, 2005	Lilly and Boehringer Ingelheim Jointly Announce the Recision of U.S. FDA Application for Duloxetine for Treatment of Stress Urinary Incontinence
Jan 27, 2005	Eli Lilly and Company Responds to BMJ Apology and Retraction
Jan 26, 2005	Lilly ICOS LLC Reports Results for 2004
Jan 26, 2005	Lilly Delivers 10 Percent Top Line Growth for Full Year 2004
Jan 24, 2005	Cialis(R) (tadalafil) Joins BASS as Premiere Sponsor
Jan 13, 2005	Lilly Launches Public Outreach Initiative to Correct Allegations About Company and Prozac
Jan 6, 2005	Lilly Revises Conference Call Time for Fourth-Quarter and Full-Year 2004 Earnings Announcement
Jan 5, 2005	Lilly Affirms: No 'Missing' Prozac Documents and No New Scientific Information
Jan 5, 2005	Lilly Provides Financial Support and Medicines for Tsunami Relief in Southeast Asia
Jan 5, 2005	New Treatment for Depression Approved in Europe
Jan 3, 2005